Literature DB >> 1939957

The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders.

J S Stamler1, J Loscalzo.   

Abstract

Organic nitrates, cornerstones of antianginal therapy, are believed to exert their principal anti-ischemic benefit by relaxing vascular smooth muscle. Recent evidence suggests that these compounds and related nitro(so) vasodilators are also potent platelet inhibitors. In view of the well recognized role of thrombotic events mediated by platelets in acute coronary syndromes, the antiplatelet effect of nitrates may also be of mechanistic importance in the treatment of these disorders. This review details the biochemical mechanism by which nitro(so) compounds inhibit platelet function and summarizes the in vitro and in vivo evidence that supports their antithrombotic effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939957     DOI: 10.1016/0735-1097(91)90686-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.

Authors:  I L Megson; N Sogo; F A Mazzei; A R Butler; J C Walton; D J Webb
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Inhibition of platelet aggregation by transdermal glyceryl trinitrate.

Authors:  R Andrews; J A May; J Vickers; S Heptinstall
Journal:  Br Heart J       Date:  1994-12

3.  Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.

Authors:  Andrew S Holmes; Yuliy Y Chirkov; Scott R Willoughby; Susan Poropat; Jeremy Pereira; John D Horowitz
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

Review 4.  Nitrates for unstable angina.

Authors:  U Thadani; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

5.  Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

Authors:  D Salvemini; M G Currie; V Mollace
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning.

Authors:  E K Iliodromitis; C C Papadopoulos; M Markianos; I A Paraskevaidis; Z S Kyriakides; D T Kremastinos
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

7.  Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation.

Authors:  Laura Dugo; Stefania Marzocco; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Achille P Caputi; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

8.  Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris.

Authors:  N H Wallén; A Andersson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

9.  Effects of nitrite and far-red light on coagulation.

Authors:  Nadeem Wajih; Elmira Alipour; Fernando Rigal; Jiqing Zhu; Andreas Perlegas; David L Caudell; Daniel Kim-Shapiro
Journal:  Nitric Oxide       Date:  2020-11-30       Impact factor: 4.427

Review 10.  Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation.

Authors:  J B Weinberg
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.